Summary
A reliable and sensitive high-performance liquid chromatographic method for the determination of the recent antidepressant citalopram and two metabolites in human plasma has been developed. Fluorescence detection at 300 nm was used, exciting at 238 nm. Separation was obtained using a reversed-phase column (C18, 250 × 3.0 mm i.d., 5 μm) and a mobile phase. 40% acetonitrile: 60% aqueous tetramethylammonium perchlorate (pH 1.9). Calibration curves were linear over a working range: 5–300 ng mL−1 for citalopram, 2.5–150.0 ng mL−1 for desmethylcitalopram and 2.5–50.0 ng mL−1 for didesmethylcitalopram. The limits of quantitation (LOQ) were 1.5 ng mL−1 for citalopram and desmethylcitalopram and 2.0 ng mL−1 for didesmethylcitalopram. Precision data, as well as accuracy, were satisfactory and no interference from different psychotropic drugs was found. The method was therefore suitable for therapeutic drug monitoring of citalopram and its active metabolites in plasma of depressed patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Murray, C.J.L.; Lopez, A.D.Science 1996,274, 740–743.
Luo, H.; Richardsson, J.S.Int. Clin. Psychopharmacol. 1993,8, 3–12.
Dufour, H.; Bouchacourt, M.; Thermoz, P.; Viala, A.; Phak Rop, I.; Gouezo, F.; Durand, A.; Hopfner Petersen, H.E.Int. Clin. Psychopharmacol. 1987,2, 225–237.
Milne, R.J.; Goa, K.L.Drugs 1991,41, 450–477.
Pacher, P.; Kohegyi, E.; Kecskemeti, V.; Furst, S.Curr. Med. Chem. 2001,8, 89–100.
Baldessarini, R.J. in Goodman and Gilmans The pharmacological basis of therapeutics, 10th Edition: Goodman, L.S.; Gilman, A.; Limbird, L. E.; Gilman Goodman, A.; Hardman, J.G. Eds, McGraw-Hill, New York,2001, p. 447–485.
Preskorn, S.H. Clinical Pharmacology of Serotonin Selective Reuptake Inhibitors, Professional Communications, Caddo,1999.
Pollock, B.G.Expert Opin. Pharmacother. 2001,2, 681–698.
Lepola, U.M.; Wade, A.G.; Leinonen, E.V.; Koponen, H.J.; Frazer, J.; Sjodin, I.; Penttinen, J.T.; Pedersen, T.; Lehto, H.J.J. Clin. Psychiat. 1998,59, 528–534.
Andersen, G.; Vestergaard, K.; Riis, J.O.Lancet 1993,342, 837–839.
Salokangas, R.K.; Saarijarvi, S.; Taiminen, T.; Kallionemi, H.; Lehto, H.; Niemi, H.; Tuominen, J.; Ahola, V.; Syvalahti, E.Acta Psychiatr. Scand. 1996,94, 175–180.
Martindale The complete drug reference, 33rd Edition: Sweetman, S.C. Ed., Pharmaccutical Press, London,2002, p. 281.
Zheng, Z.; Jamour, M.; Klotz, U.Ther. Drug Monit. 2000,22, 219–224.
Fredricson Overo, K.Prog. Neuro-Psychoph. 1982,6, 311–318.
Dalgaard, L.; Larsen, C.Xenobiotica 1999,29, 1033–1041.
Bjerkenstedt, L.; Flyckt, L.; Overo, K.F.; Lingiaerde, O.Eur. J. Clin. Pharmacol. 1985,28, 553–557.
Raggi, M.A.; Mandrioli, R.; Casamenti, G.; Bugamelli, F.; Volterra, V.J. Pharmaceut. Biomed. 1998,18, 193–199.
Raggi, M.A.; Mandrioli, R.; Casamenti, G.; Volterra, V.; Desiderio, C.; Fanali, S.Chromatographia 1999,50, 423–427.
Reymond, P.; Amey, M.; Souche, A.; Lambert, S.; Konrat, H.; Eap, C.B.; Baumann, P.J. Chromatogr. 1993,616, 221–228.
Eap, C.B.; Bouchoux, G.; Amey, M.; Cochard, N.; Savary, L.; Baumann, P.J. Chromatogr. Sci. 1998,36, 365–371.
Lacassie, E.; Gaulier, J.-M.; Marquet, P.; Rabatel, J.-F.; Lachatre, G.J. Chromatogr. B 2000,742, 229–238.
Rop, P.P.; Viala, A.; Durand, A.; Conquy, T.J. Chromatogr. 1985,338, 171–178.
Akerman, K.K.; Jolkkonen, J.; Huttunen, H.; Penttila, I.Ther. Drug. Monit. 1998,20, 25–29.
Anastos, N.; McIntyre, I.M.; Lynch, M.J.; Drummer, O.H.J. Forensic Sci. 2002,47, 882–884.
Kristoffersen, L.; Bugge, A.; Lundanes, E.; Slørdal, L.J. Chromatogr. B 1999,734, 229–246.
Öhman, D.; Carlsson, B.; Norlander, B.J. Chromatogr. B 2001,753, 365–373.
Labat, L.; Deveaux, M.; Dallet, P.; Dubost, J.P.J. chromatogr. B 2002,773, 7–23.
Pucci, V.; Fanali, S.; Sabbioni, C.; Raggi, M.A.J. Sep. Sci. 2002,25, 10–16.
Berzas Nevado, J.J.; Contento Salcedo, A.M.Chromatographia 2002,55, 369–373.
United States Pharmacopeia 24th ed., United States Pharmacopeial Convention, Rockville, MD,2000, pp. 2150–2151.
Hill, H.M.Chromatographia 2000,52, 65–69.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raggi, M.A., Pucci, V., Mandrioli, R. et al. Determination of recent antidepressant citalopram in human plasma by liquid chromatography—Fluorescence detection. Chromatographia 57, 273–278 (2003). https://doi.org/10.1007/BF02492396
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02492396